Jeffrey M. Leiden is a businessperson who founded CardioGene Therapeutics, Inc. and who has been at the head of 7 different companies. Currently, he is Chairman, President & Chief Executive Officer of Vertex Pharmaceuticals, Inc. Dr. Leiden is also Member of American Academy of Arts & Sciences, Member of Institute of Medicine and Member-Institute of Medicine at National Academy of Sciences and on the board of 8 other companies.
In his past career Jeffrey M. Leiden occupied the position of Chairman at Lycera Corp., President & Chief Operating Officer of Abbott Laboratories, Chairman of TYRX, Inc., Chairman at Variation Biotechnologies (US), Inc., Managing Director at Clarus Ventures LLC, President & Chief Operating Officer for Pharmaceutical Products, Professor-Medicine & Pathology at The University of Chicago, Professor-Medicine at Harvard Medical School and Professor-Biological Sciences at Harvard T.H. Chan School of Public Health.
Jeffrey M. Leiden received a doctorate and an undergraduate degree from The University of Chicago.